We are live on ! Find out more
AVXL icon

Anavex Life Sciences

141 hedge funds and large institutions have $232M invested in Anavex Life Sciences in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $15.9M | Put options by funds: $9.03M

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 139141 (+2)

5% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 40

0.14% more ownership

Funds ownership: 34.61%34.74% (+0.14%)

7% less capital invested

Capital invested by funds: $249M → $232M (-$17.2M)

Holders
141
Holders Change
+2
Holders Change %
+1.44%
% of All Funds
2.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
42
Reduced
40
Closed
16
Calls
$15.9M
Puts
$9.03M
Net Calls
+$6.9M
Net Calls Change
+$17.8M
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$768K
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$767K +$32.2K +3,227 +4%
CS
28
Credit Suisse
Switzerland
$764K +$41.8K +4,191 +5%
PA
29
Profund Advisors
Maryland
$736K +$857K +85,912 New
HP
30
Hikari Power
Japan
$733K
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$709K +$93.5K +9,366 +13%
CAN
32
Cetera Advisor Networks
California
$676K +$92.7K +9,287 +13%
Millennium Management
33
Millennium Management
New York
$674K -$7.53M -754,876 -91%
HWAM
34
Hennion & Walsh Asset Management
New Jersey
$605K -$16.5K -1,658 -2%
VF
35
Virtu Financial
New York
$586K +$387K +38,751 +131%
AWM
36
AllSquare Wealth Management
New York
$565K
Simplex Trading
37
Simplex Trading
Illinois
$524K +$611K +61,205 New
TI
38
Trexquant Investment
Connecticut
$512K -$1.23M -123,418 -67%
JP Morgan Chase
39
JP Morgan Chase
New York
$495K +$137K +13,748 +31%
DekaBank Deutsche Girozentrale
40
DekaBank Deutsche Girozentrale
Germany
$449K
Mirae Asset Global Investments
41
Mirae Asset Global Investments
South Korea
$443K +$175K +17,579 +51%
AA
42
ALPS Advisors
Colorado
$441K -$15.1K -1,511 -3%
Deutsche Bank
43
Deutsche Bank
Germany
$431K +$90.1K +9,027 +22%
LPL Financial
44
LPL Financial
California
$421K +$55.1K +5,525 +13%
PFG
45
Prosperity Financial Group
California
$411K
Marshall Wace
46
Marshall Wace
United Kingdom
$409K +$127K +12,704 +36%
CIC
47
Carnegie Investment Counsel
Ohio
$374K +$249K +24,925 +133%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$365K +$4.26K +427 +1%
GWM
49
Geneos Wealth Management
Colorado
$361K +$20K +2,000 +5%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$351K

AVXL Hedge Fund Activity: Q1 2023 in Review

141 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2023, worth a combined $232M — down 6.9% from $249M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AVXL positions and 16 closed out — a net gain of 2 holders — while 42 added to existing stakes and 40 trimmed.

The largest buyer was NWAM LLC, opening a new position worth an estimated $5.47M. The largest seller was Millennium Management, cutting an estimated $7.53M.

  • 141 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2023, up from 139 in Q4 2022.
  • Funds reported $232M of Anavex Life Sciences stock for Q1 2023, down 6.9% quarter-over-quarter.
  • 18 funds opened new Anavex Life Sciences positions in Q1 2023 and 16 closed out, a net change of +2 holders.
  • The largest Anavex Life Sciences buyer in Q1 2023 was NWAM LLC, an estimated $5.47M added.
  • The largest Anavex Life Sciences seller in Q1 2023 was Millennium Management, an estimated $7.53M sold.

Based on aggregated 13F filings for Q1 2023.